{"disease":{"id":"macular-degenerative-disease","name":"macular degenerative disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06965426","title":"Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,","has_results":false},{"nct_id":"NCT03167203","title":"A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":36,"lead_sponsor_name":"Astellas Institute for Regenerative Medicine","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}